BIOMAT Database Logo BIOMAT Database Logo

Multidrug-resistant tuberculosis in South Africa. 1996

K Weyer, and M F Stander

UI MeSH Term Description Entries
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013019 South Africa A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria (administrative), Cape Town (legislative), and Bloemfontein (judicial). Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960. Republic of South Africa,Union of South Africa
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises
D018088 Tuberculosis, Multidrug-Resistant Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS. Tuberculosis, Drug-Resistant,Tuberculosis, MDR,Tuberculosis, Multi-Drug Resistant,Drug-Resistant Tuberculosis,MDR Tuberculosis,Multi-Drug Resistant Tuberculosis,Multidrug-Resistant Tuberculosis,Tuberculosis, Drug Resistant,Tuberculosis, Multi Drug Resistant,Tuberculosis, Multidrug Resistant

Related Publications

K Weyer, and M F Stander
Multidrug resistant tuberculosis in South Africa.
June 1996, Lancet (London, England),
K Weyer, and M F Stander
Multidrug-resistant tuberculosis outbreak in South Africa.
February 2019, The Lancet. Infectious diseases,
K Weyer, and M F Stander
Multidrug-resistant tuberculosis outbreak in South Africa - Authors' reply.
February 2019, The Lancet. Infectious diseases,
K Weyer, and M F Stander
Community-based management of multidrug-resistant tuberculosis in South Africa.
April 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
K Weyer, and M F Stander
Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.
June 2013, Journal of clinical microbiology,
K Weyer, and M F Stander
Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis.
April 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
K Weyer, and M F Stander
Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa.
April 2014, Infection,
K Weyer, and M F Stander
Multidrug-resistant malaria from South Africa.
February 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
K Weyer, and M F Stander
Major Depression and Stigma among Individuals with Multidrug-Resistant Tuberculosis in South Africa.
September 2020, The American journal of tropical medicine and hygiene,
K Weyer, and M F Stander
Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
April 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Copied contents to your clipboard!